|Bid||4.17 x 1100|
|Ask||5.05 x 2100|
|Day's Range||4.31 - 4.59|
|52 Week Range||0.04 - 30.41|
|PE Ratio (TTM)||-0.40|
|Earnings Date||May 4, 2017 - May 8, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||11.00|
Q1 2017 EnteroMedics Inc Earnings Call
ST. PAUL, Minn., May 18, 2017 /PRNewswire/ -- EnteroMedics Inc. (ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the McGuire Veterans Affairs Medical Center (Richmond VAMC) in Richmond, VA successfully completed its first implant of the Company's vBloc® Neurometabolic Therapy. The surgery was performed earlier this week by James Maher, MD.
On a per-share basis, the St. Paul, Minnesota-based company said it had a loss of $1.27. The medical device company posted revenue of $40,000 in the period. EnteroMedics shares have more than tripled since ...